glp-1 sarcopenia Weighing the risk of treatment in older adults: Should we be concerned about sarcopenic obesity? Exploring the Side Effects of
Description
Despite this, tirzepatide's weight loss results were remarkable, making it a promising treatment for those focused on both weight loss and glucose control
doi: 10.1111/j.1365-2036.2006.02728.x
A minimum protein intake of 1 g/kg/day is recommended to maintain muscle mass in older adults [107]
However, when the gut is inflamed or imbalanced (a condition known as dysbiosis), GLP-1 production can be impaired
Transitioning from Ozempic to Wegovy requires re-titration starting at 0.25 mg and is only appropriate for patients meeting BMI criteria (30 kg/m or 27 kg/m with weight-related comorbidities)
